Karen Dybkær
-
- Lymphoma Diagnosis and Treatment 35
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 13
- MicroRNA in disease regulation 7
- Cancer-related molecular mechanisms research 7
- Immunology top 5%
- Immune Cell Function and Interaction 9
- Oncology top 5%
- CAR-T cell therapy research 8
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 19
-
- Multiple Myeloma Research and Treatments 11
- Co-authors
- Hans Erik JohnsenMartin BøgstedAlexander SchmitzJulie Støve BødkerJaveed IqbalHuimin GengWing C. ChanTarec Christoffer El‐Galaly
- Journals
- Journal of Biological Chemistry (1 paper)SHILAP Revista de lepidopterología (1 paper)Blood (7 papers)
- Partner nations
- DenmarkUnited StatesSpain
In The Last Decade
Karen Dybkær
95 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 130
- Pathology and Forensic Medicine 621
- Cancer Research 393
- Immunology 545
- Oncology 604
- Genetics 209
Countries citing papers authored by Karen Dybkær
This map shows the geographic impact of Karen Dybkær's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Dybkær with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Dybkær more than expected).
Fields of papers citing papers by Karen Dybkær
This network shows the impact of papers produced by Karen Dybkær. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Dybkær. The network helps show where Karen Dybkær may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Karen Dybkær, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 11 | |
| 8 | 2021 | 12 | |
| 9 | 2020 | 13 | |
| 10 | 2020 | 11 | |
| 11 | 2020 | 3 | |
| 12 | 2020 | 8 | |
| 13 | 2018 | 7 | |
| 14 | Low Expression of Mir-155 in Vincristine Resistant Diffuse Large B-Cell Lymphoma | 2016 | 1 |
| 15 | 2015 | 70 | |
| 16 | 2014 | 14 | |
| 17 | 2013 | 19 | |
| 18 | 2012 | 1 | |
| 19 | 2010 | 50 | |
| 20 | 2000 | 7 |
About Karen Dybkær
Karen Dybkær is a scholar working on Genetics, Pathology and Forensic Medicine and Cancer Research, having authored 102 papers that have together received 1.9k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (35 papers), Chronic Lymphocytic Leukemia Research (19 papers), Cancer Genomics and Diagnostics (13 papers), Multiple Myeloma Research and Treatments (11 papers), Immune Cell Function and Interaction (9 papers), CAR-T cell therapy research (8 papers), MicroRNA in disease regulation (7 papers) and Cancer-related molecular mechanisms research (7 papers). The work is most often cited by research in Pathology and Forensic Medicine (621 citations), Cancer Research (393 citations) and Immunology (545 citations). Karen Dybkær has collaborated with scholars based in Denmark, United States and Spain. Frequent co-authors include Hans Erik Johnsen, Martin Bøgsted, Alexander Schmitz, Julie Støve Bødker, Javeed Iqbal, Huimin Geng, Wing C. Chan, Tarec Christoffer El‐Galaly, Steffen Falgreen and Malene Krag Kjeldsen. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.